Company intelligence / Profile preview

Edge Pharmaceuticals

Pompano Beach / Coral Springs area, Florida, United Statesedgepharm.com ↗

Ownership: Private
Development stage: Other

Overview

Edge Pharmaceuticals was a leading provider of conventional and specialty compounded products for allergy testing and treatment, including bulk allergenic extracts, diluents, skin testing devices, metered dose dropper bottles, and sublingual immunotherapy capsules. The company was acquired by Edge Pharma in January 2020 to form a more comprehensive platform for allergy immunotherapy solutions.

Therapeutic areas: Immunology
Modalities: Small moleculeBiologic (for allergy extracts and immunotherapy)Compounded drug products
Industry: Biotech

Partnerships

Edge Pharmaceuticals had longstanding relationships with manufacturers and healthcare providers in the US allergy market. Post-acquisition partnerships are managed under the parent company.

Beyond the preview

Go deeper on Edge Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Edge Pharmaceuticals.

Explore the full profile